You know damn well whytee that Rem-L is indicated for a different (later) phase of COVID (when other treatments have failed to prevent the patient from developing acute respiratory distress syndrome). That's right, people still progressing to this stage with all the other antiviral treatments, monoclonals etc (deaths are still occurring last time I checked). You are circling the bottom now whytee.
Your logic is not too far short of saying:
New improved formula in minor burns gel: Gameover for technologies in the treatment of burns
Quicker absorbed paracetamol: Gameover for all prescription migraine medications
Pfizer Covid Pill: Gameover for MSB's treatment, page-7
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.09 | $4.556M | 4.141M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9590 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 3132 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |